BASF appoints Folker Ruchatz as head of its global custom synthesis business
Effective January 2008 Dr. Folker Ruchatz has been given global responsibility for the custom synthesis business within BASF's business unit Pharma Ingredients & Services. He has also been appointed managing director of BASF Orgamol Pharma Solutions SA. The company manufactures active ingredients and highly refined intermediates for the pharmaceutical industry.
Dr. Folker Ruchatz joined BASF in 1996 and has held various positions in marketing and product development. Most recently, he was responsible for the Pharma Solutions and Dietary Supplements business unit in North America.
Dr. Folker Ruchatz studied pharmacy at the University of Kiel, Germany, and was awarded a doctorate in natural sciences.
Other news from the department people
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
